Introduction

Chromatography plays a central role in modern biomolecule purification, supporting applications ranging from protein research to large-scale biopharmaceutical manufacturing. Traditional single-mode chromatography techniques such as ion exchange, affinity chromatography, hydrophobic interaction chromatography, and size exclusion chromatography have long been considered standard approaches for separating proteins and other biological molecules.

However, the rapid development of complex biologics has introduced purification challenges that are increasingly difficult to address using conventional single-interaction systems alone. Molecules such as bispecific antibodies, antibody-drug conjugates (ADCs), fusion proteins, viral vectors, and nucleic acid therapeutics often exhibit high structural similarity to impurities, making selective separation more complicated.

As a result, multimode chromatography has emerged as an increasingly important purification strategy capable of improving selectivity and downstream process efficiency.

Understanding Traditional Single-Mode Chromatography

Traditional chromatography methods rely primarily on one dominant interaction mechanism between the target molecule and the chromatography matrix. Separation is achieved based on a single physicochemical property such as charge, size, hydrophobicity, or ligand specificity.

Common single-mode chromatography approaches include:

• ion exchange chromatography for charge-based separation
• affinity chromatography for specific ligand binding
• hydrophobic interaction chromatography for surface hydrophobicity
• size exclusion chromatography for molecular size separation

These methods remain highly effective for many purification workflows due to their scalability, reproducibility, and relatively straightforward optimization. In many standard protein purification processes, single-mode chromatography continues to provide reliable performance and high product purity.

However, challenges arise when target molecules and impurities share similar physicochemical characteristics.

What Is Multimode Chromatography?

Multimode chromatography, also known as mixed-mode chromatography, combines multiple interaction mechanisms within a single chromatography resin or ligand system. Instead of depending on one separation principle, multimode systems integrate several molecular interactions simultaneously.

These interactions may include:

• ionic interactions
• hydrophobic interactions
• hydrogen bonding
• van der Waals interactions

This multifunctional binding behavior allows multimode chromatography to achieve higher selectivity and improved impurity discrimination compared with conventional single-mode systems.

Unlike traditional methods that separate molecules according to one dominant property, multimode chromatography creates a more complex interaction environment capable of distinguishing structurally related biomolecules more effectively.

Key Differences Between Multimode and Single-Mode Chromatography

One of the most important differences lies in selectivity. Traditional methods can efficiently separate molecules with distinct properties, but their performance decreases when target molecules closely resemble contaminants or structural variants.

Multimode chromatography addresses this limitation by introducing multiple binding mechanisms that improve separation flexibility and resolution.

Why Complex Biologics Are Driving the Shift Toward Multimode Chromatography

The growing complexity of modern biologics is one of the primary reasons multimode chromatography has gained attention in downstream processing.

Many next-generation therapeutics exhibit significant heterogeneity, including:

• charge variants
• protein aggregates
• truncated forms
• conjugated payload variations
• post-translational modification heterogeneity

For example, antibody-drug conjugates contain multiple molecular populations with different drug-to-antibody ratios, while bispecific antibodies often generate structurally similar byproducts during production.

These subtle differences can be difficult to resolve using single-mode purification alone. Multimode chromatography improves the ability to separate these closely related species by combining multiple interaction mechanisms within one purification platform.

Advantages of Multimode Chromatography

One major advantage of multimode chromatography is improved process flexibility. Because multiple interaction modes contribute to separation behavior, purification conditions can be adjusted more precisely to optimize selectivity.

Multimode systems may also reduce the number of purification steps required during downstream processing, improving workflow efficiency and potentially lowering manufacturing costs.

Additional advantages include:

• enhanced impurity clearance
• improved aggregate removal
• better separation of structurally related variants
• broader operating conditions compared with some traditional methods

These characteristics are particularly valuable in biopharmaceutical manufacturing environments where purity requirements are highly stringent.

Challenges and Limitations

Despite its advantages, multimode chromatography also introduces additional technical complexity. Since multiple molecular interactions occur simultaneously, process optimization can be more difficult than with traditional chromatography systems.

Variables such as pH, salt concentration, buffer composition, and flow rate may influence several interaction mechanisms at once. As a result, predicting chromatographic behavior becomes more challenging.

Another limitation is process development time. Multimode systems often require extensive screening and optimization to identify appropriate operating conditions for specific molecules.

In some applications, traditional single-mode chromatography may still provide a more practical and cost-effective solution, especially when purification targets are well characterized and relatively simple.

Applications in Modern Biopharmaceutical Purification

Multimode chromatography is increasingly used in the purification of monoclonal antibodies, fusion proteins, recombinant enzymes, viral vectors, and nucleic acid therapeutics.

In mRNA and gene therapy manufacturing, multimode systems are being explored to address purification bottlenecks associated with molecular instability and impurity complexity. In antibody purification workflows, multimode chromatography is commonly used to improve removal of host cell proteins, aggregates, endotoxins, and charge variants.

Its growing role in advanced biologics purification reflects the broader shift toward more selective and adaptable downstream processing technologies.

Conclusion

Traditional single-mode chromatography continues to serve as a foundational technology in biomolecule purification due to its reliability, scalability, and established performance. However, the increasing structural complexity of modern biologics has created growing demand for more flexible and selective purification strategies.

By integrating multiple interaction mechanisms into a single system, multimode chromatography provides improved selectivity and enhanced impurity resolution for challenging purification applications. Although optimization can be more complex, its advantages in handling structurally heterogeneous biomolecules have made it an increasingly important technology in advanced biopharmaceutical development and downstream processing.